120 related articles for article (PubMed ID: 11209982)
1. Hyperhomocysteinaemia and atherothrombosis.
Cattaneo M
Ann Med; 2000 Dec; 32 Suppl 1():46-52. PubMed ID: 11209982
[TBL] [Abstract][Full Text] [Related]
2. Hyperhomocysteinemia and thrombosis.
Cattaneo M
Lipids; 2001; 36 Suppl():S13-26. PubMed ID: 11837987
[TBL] [Abstract][Full Text] [Related]
3. Hyperhomocysteinemia, atherosclerosis and thrombosis.
Cattaneo M
Thromb Haemost; 1999 Feb; 81(2):165-76. PubMed ID: 10063987
[TBL] [Abstract][Full Text] [Related]
4. Homocysteine and arterial thrombosis: Challenge and opportunity.
Di Minno MN; Tremoli E; Coppola A; Lupoli R; Di Minno G
Thromb Haemost; 2010 May; 103(5):942-61. PubMed ID: 20352150
[TBL] [Abstract][Full Text] [Related]
5. Homocysteine and thrombosis: from basic science to clinical evidence.
Undas A; Brozek J; Szczeklik A
Thromb Haemost; 2005 Nov; 94(5):907-15. PubMed ID: 16363230
[TBL] [Abstract][Full Text] [Related]
6. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
[TBL] [Abstract][Full Text] [Related]
7. Folic acid 5 or 15 mg/d similarly reduces plasma homocysteine in patients with moderate-advanced chronic renal failure.
Bernasconi AR; Liste A; Del Pino N; Rosa Diez GJ; Heguilén RM
Nephrology (Carlton); 2006 Apr; 11(2):137-41. PubMed ID: 16669976
[TBL] [Abstract][Full Text] [Related]
8. [Homocysteine and cardiovascular risk].
Auer J; Berent R; Weber T; Lassnig E; Eber B
Wien Med Wochenschr; 2001; 151(1-2):25-8. PubMed ID: 11234594
[TBL] [Abstract][Full Text] [Related]
9. Novel risk factors for vascular disease: the homocysteine hypothesis of cardiovascular disease.
Wilcken DE
J Cardiovasc Risk; 1998 Aug; 5(4):217-21. PubMed ID: 9919468
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients.
Nakhoul F; Abassi Z; Plawner M; Khankin E; Ramadan R; Lanir N; Brenner B; Green J
Isr Med Assoc J; 2004 Apr; 6(4):213-7. PubMed ID: 15115259
[TBL] [Abstract][Full Text] [Related]
11. Plasma homocysteine and folate levels in patients with chronic plaque psoriasis.
Malerba M; Gisondi P; Radaeli A; Sala R; Calzavara Pinton PG; Girolomoni G
Br J Dermatol; 2006 Dec; 155(6):1165-9. PubMed ID: 17107384
[TBL] [Abstract][Full Text] [Related]
12. Hyperhomocysteinaemia and risk of thrombosis in systemic lupus erythematosus patients.
Refai TM; Al-Salem IH; Nkansa-Dwamena D; Al-Salem MH
Clin Rheumatol; 2002 Nov; 21(6):457-61. PubMed ID: 12447627
[TBL] [Abstract][Full Text] [Related]
13. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
[TBL] [Abstract][Full Text] [Related]
14. Aetiology and treatment of hyperhomocysteinaemia causing ischaemic stroke.
Sarkar PK; Lambert LA
Int J Clin Pract; 2001 May; 55(4):262-8. PubMed ID: 11406912
[TBL] [Abstract][Full Text] [Related]
15. Homocysteine-lowering is not a primary target for cardiovascular disease prevention in chronic kidney disease patients.
Suliman ME; Lindholm B; Bárány P; Qureshi AR; Stenvinkel P
Semin Dial; 2007; 20(6):523-9. PubMed ID: 17991198
[TBL] [Abstract][Full Text] [Related]
16. Enhanced risk of thrombotic disease in patients with acquired vitamin B12 and/or folate deficiency: role of hyperhomocysteinemia.
Remacha AF; Souto JC; Rámila E; Perea G; Sarda MP; Fontcuberta J
Ann Hematol; 2002 Nov; 81(11):616-21. PubMed ID: 12454698
[TBL] [Abstract][Full Text] [Related]
17. Association of B vitamins status and homocysteine levels in elderly Taiwanese.
Chen KJ; Pan WH; Yang FL; Wei IL; Shaw NS; Lin BF
Asia Pac J Clin Nutr; 2005; 14(3):250-5. PubMed ID: 16169836
[TBL] [Abstract][Full Text] [Related]
18. [Hyperhomocysteinemia. A new coronary risk factor].
Zacarías-Castillo R; Hernández-Rebollar AE; Zajarias-Rabchinskey A; González-Bárcena D
Gac Med Mex; 2001; 137(4):335-45. PubMed ID: 11519357
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of vascular disease in hyperhomocysteinaemia.
Domagała TB; Undas A; Libura M; Szczeklik A
J Cardiovasc Risk; 1998 Aug; 5(4):239-47. PubMed ID: 9919472
[TBL] [Abstract][Full Text] [Related]
20. Impairment of coronary circulation by acute hyperhomocysteinaemia and reversal by antioxidant vitamins.
Coppola A; Astarita C; Liguori E; Fontana D; Oliviero M; Esposito K; Coppola L; Giugliano D
J Intern Med; 2004 Nov; 256(5):398-405. PubMed ID: 15485475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
